Free tool
Heavily traded stocks
We cover 83 companies whose typical session turns over more than $10.00M. The median market value in the group is $2.99B. Across the group, the median move over the past trading day is +0.79%. 70% of the 83 with a 200-day average trade above it. Price change over the past year runs from −27.8% to +47.8% across the middle 80 percent of the group, with a median of +4.3%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
83 of 7,336 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| SAN.PA | Sanofi | 78.74 EUR | −1.48% | +1.00% | −2.60% |
| GSK.L | GSK plc | 1,905.50 GBP | −5.06% | +4.06% | +30.59% |
| EL.PA | EssilorLuxottica Société anonyme | 159.15 EUR | −3.60% | −38.64% | −38.15% |
| MRK.DE | Merck KGaA | 139.35 EUR | −3.96% | +17.18% | +32.17% |
| BAYN.DE | Bayer Aktiengesellschaft | 49.26 EUR | +3.29% | +30.00% | +76.91% |
| SHL.DE | Siemens Healthineers AG | 39.70 EUR | +5.75% | −7.90% | −14.18% |
| HLN.L | Haleon plc | 369.60 GBP | −2.66% | −0.12% | +2.68% |
| FRE.DE | Fresenius SE & Co. KGaA | 45.85 EUR | +2.98% | −1.28% | +1.64% |
| DIM.PA | Sartorius Stedim Biotech S.A. | 194.30 EUR | +13.49% | −6.30% | +11.64% |
| GMAB.CO | Genmab A/S | 2,196.00 DKK | +17.62% | +9.42% | +36.19% |
| SRT3.DE | Sartorius Aktiengesellschaft | 246.50 EUR | +9.26% | −0.18% | +25.88% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | 469.60 SEK | −0.76% | +42.13% | +61.26% |
| IPN.PA | Ipsen S.A. | 166.00 EUR | +1.41% | +42.98% | +40.80% |
| COLO-B.CO | Coloplast A/S | 462.50 DKK | +6.22% | −12.68% | −20.60% |
| ERF.PA | Eurofins Scientific SE | 74.08 EUR | +7.93% | +20.90% | +15.60% |
| ORNBV.HE | Orion Oyj | 80.80 EUR | −1.76% | +29.38% | +21.01% |
| FME.DE | Fresenius Medical Care AG | 40.36 EUR | −7.39% | +4.49% | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | 52.70 EUR | +2.53% | +10.68% | +1.80% |
| SN.L | Smith & Nephew plc | 1,068.00 GBP | −12.06% | −12.27% | −22.42% |
| BIM.PA | bioMérieux S.A. | 75.50 EUR | +3.64% | −31.05% | −35.91% |
| ABVX.PA | ABIVAX Société Anonyme | 102.30 EUR | −5.63% | −11.04% | +48.91% |
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| ALK-B.CO | ALK-Abelló A/S | 208.80 DKK | −6.62% | −7.16% | +5.09% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | 42.68 DKK | +1.19% | +2.35% | +8.99% |
| CTEC.L | Convatec Group PLC | 228.80 GBP | −0.78% | −4.49% | −1.95% |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | 1,640.00 GBP | +0.61% | +7.71% | −9.62% |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% |
| ZEAL.CO | Zealand Pharma A/S | 326.90 DKK | +7.15% | −28.95% | −25.94% |
| BIOA-B.ST | BioArctic AB (publ) | 345.00 SEK | +6.35% | +11.66% | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% |
| AMBU-B.CO | Ambu A/S | 78.40 DKK | +8.59% | −9.10% | −19.13% |
| BAVA.CO | Bavarian Nordic A/S | 218.20 DKK | +23.42% | +13.17% | −7.97% |
| ONT.L | Oxford Nanopore Technologies plc | 183.00 GBP | +62.81% | +42.97% | −2.24% |
| EKTA-B.ST | Elekta AB (publ) | 56.05 SEK | +14.95% | +0.87% | +26.10% |
| GN.CO | GN Store Nord A/S | 94.54 DKK | −2.03% | −13.98% | −18.50% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% |
| ATT.ST | Attendo AB (publ) | 117.90 SEK | +7.57% | +49.22% | +80.74% |
| BONEX.ST | Bonesupport Holding AB (publ) | 224.40 SEK | +1.54% | +26.07% | −28.26% |
| AMBEA.ST | Ambea AB (publ) | 173.60 SEK | +21.74% | +27.37% | +38.66% |
| VITR.ST | Vitrolife AB (publ) | 95.10 SEK | +9.31% | −27.76% | −30.23% |
| CHEMM.CO | ChemoMetec A/S | 496.80 DKK | +15.59% | −26.35% | −3.94% |
| UPR.L | Uniphar plc | 370.00 GBP | −1.33% | +23.75% | +6.94% |
| SPI.L | Spire Healthcare Group plc | 237.00 GBP | +1.28% | +40.25% | +7.25% |
| BIOG-B.ST | BioGaia AB (publ) | 117.10 SEK | +1.39% | +15.05% | +13.96% |
| CVSG.L | CVS Group plc | 1,296.00 GBP | +3.27% | +1.73% | +2.05% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | 278.80 SEK | +9.08% | +53.95% | +59.31% |
| DYVOX.ST | Dynavox Group AB (publ) | 76.70 SEK | +4.14% | −21.71% | −39.29% |
| OXB.L | Oxford Biomedica plc | 515.00 GBP | −5.68% | −21.37% | −9.81% |
| AMS.L | Advanced Medical Solutions Group plc | 281.50 GBP | +0.36% | +29.14% | +38.01% |
| SNT.WA | Synektik Spólka Akcyjna | 338.40 PLN | −5.58% | +21.82% | +53.07% |
| CRW.L | Craneware plc | 1,272.00 GBP | +2.75% | −33.40% | −40.83% |
| RAY-B.ST | RaySearch Laboratories AB (publ) | 181.70 SEK | +3.06% | −15.47% | −29.98% |
| HNSA.ST | Hansa Biopharma AB (publ) | 43.30 SEK | +19.22% | +32.42% | +35.65% |
| AVCT.L | Avacta Group Plc | 69.50 GBP | +0.72% | +20.87% | +26.36% |
| PRTC.L | PureTech Health plc | 121.20 GBP | +0.17% | −2.73% | −4.27% |
| NIOX.L | NIOX Group Plc | 66.60 GBP | +8.82% | −2.03% | −9.49% |
| CRNA.OL | Circio Holding ASA | 11.92 NOK | +37.80% | +877.05% | +1733.85% |
| OPT.L | Optima Health plc | 240.50 GBP | +1.48% | +20.85% | +9.32% |
| ANCR.L | Animalcare Group PLC | 335.00 GBP | 0.00% | +40.76% | +28.86% |
| TSTL.L | Tristel plc | 425.00 GBP | +1.19% | −2.84% | +19.76% |
| SCLP.L | Scancell Holdings plc | 9.70 GBP | −2.02% | −2.02% | −7.62% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| EAH.L | ECO Animal Health Group plc | 99.00 GBP | +1.54% | −6.60% | +34.69% |
| POLB.L | Poolbeg Pharma PLC | 8.60 GBP | +36.51% | +120.51% | +164.62% |
| MPAL.L | MedPal AI PLC | 3.75 GBP | +22.95% | −25.00% | −40.00% |
| ALNEV.PA | Neovacs S.A. | 0.55 EUR | −31.22% | +6150.00% | −11.29% |
| ALC.SW | Alcon Inc. | 58.72 CHF | +2.77% | −7.14% | −7.46% |
| GALD.SW | Galderma Group AG | 171.00 CHF | −3.44% | +7.04% | +22.58% |
| LONN.SW | Lonza Group AG | 587.80 CHF | +2.26% | +10.90% | +4.28% |
| NOVN.SW | Novartis AG | 128.34 CHF | −1.08% | +21.88% | +30.24% |
| ROP.SW | Roche Holding AG | 373.80 CHF | +3.35% | +18.35% | +47.60% |
| SDZ.SW | Sandoz Group AG | 73.54 CHF | +9.01% | +30.08% | +47.80% |
| SOON.SW | Sonova Holding AG | 245.00 CHF | +10.16% | +17.62% | +6.01% |
| STMN.SW | Straumann Holding AG | 91.54 CHF | −10.52% | −1.85% | −2.20% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.